¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25
±³À°ÀÏÀÚ : 2024-05-25
±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ 5Ãþ À̺¥Æ®È¦A+B ¿Ü 1°³·ë

±³À°ÁÖÁ¦ : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ

´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070

À̸ÞÀÏ : office@intervention.or.kr

±³À°Á¾·ù : ¿µ»óÀÇÇаú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í »çÀüµî·Ï-Á¤È¸¿ø50000¿ø, Àü¹®ÀÇ100000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 30000¿ø, ÁØȸ¿ø¹×±âŸ 50000¿ø/ÇöÀåµî·Ï-Á¤È¸¿ø70000¿ø, Àü¹®ÀÇ120000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 50000¿ø, ÁØȸ¿ø¹×±âŸ 70000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:00~09:12 (±¸¿¬¹ßÇ¥) Outcomes of Femoral Arteriovenous Accesses for Hemodialysis: A Comparative Study of Fistulas and Grafts Á¤Á¦¿ø(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:12~09:24 (±¸¿¬¹ßÇ¥) Comparison of computed tomography (CT) and endoscopic findings before and after vascular plug-assisted retrograde transvenous obliteration (PARTO) and assessment of treatment outcomes À̵¿±Ô(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:24~09:36 (±¸¿¬¹ßÇ¥) Balloon-occluded antegrade transvenous obliteration for refractory esophageal variceal bleeding alternative to transjugular intrahepatic portosystemic shunt creation: A single center retrospective study ½Éµ¿Àç(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:36~09:48 (±¸¿¬¹ßÇ¥) Safety and Efficacy of Coil Embolization of the Venous Segment of Type IIa Pelvic Arteriovenous Malformations ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:48~10:00 (±¸¿¬¹ßÇ¥) New treatment strategy of type IIIb Cho-Do angiographic classification of AVM: Single referral vascular anomalies center experience À̰濬(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:00~10:20 Coffee break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:20~10:40 HD via fistula from a perspectives of nephrologist ÃÖÁؼ®(¸ñÆ÷´õÁ¶Àº³»°ú)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:40~11:00 AVF/AVG intervention in private clinics ±è¿ëÅÂ(±¤Á̷ֹ¡ÀÇ¿ø)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:00~11:20 When surgical revision is considered ¹è¹ÌÁÖ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:20~11:50 º¸°ÇÀÇ·áȯ°æ º¯È­¿Í ¿µ»óÀÇÇаú ¿ÀÁÖÇü(°æÈñÀÇ´ë)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:50~12:10 ÃÑȸ ()

ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:10~12:20 Coffee break ()

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:20~12:25 Luncheon Symposium Opening Remark ()

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:25~12:45 Recent Outcomes of Yttrium-90 Glass-Microsphere in early to intermediate stage : Global & Korea Çöµ¿È£(¼º±Õ°üÀÇ´ë)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:45~13:05 Simplicity90Y : A highway to personalized dosimetry ÃÖÁø¿ì(¼­¿ïÀÇ´ë)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:05~13:15 Discussion ()

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:15~13:20 Luncheon Symposium Closing Remark ()

ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:20~13:40 Coffee break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:40~14:00 Acute limb ischemia: overview from IR perspective, Treatment with CDT ±èÁØ°ï, Á¶¼ö¹ü(¼º±Õ°üÀÇ´ë, ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:00~14:20 Treatment with other PMT methods, surgical thromboembolectomy Á¶¿µÁ¾, °íÈ£Çö(¿ï»êÀÇ´ë, ÇѸ²ÀÇ´ë)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:20~14:50 Strategy for acute limb ischemia Case À±Á¾Çõ, ±è°ÇÇÏ, °­Ã¤ÈÆ(°í½ÅÀÇ´ë, ¿ï»êÀÇ´ë, À»ÁöÀÇ´ë)

Åä·Ð 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:50~15:00 Discussion ()

ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:00~15:20 Coffee break ()

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:20~15:35 The Convergence of AI, Engineering, and Medicine ÇÔ¼º¿ø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:35~15:50 Ultrasound with AR ¹Ú¼ºÁØ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:50~16:05 Development of an integrated system for active precise delivery of embolic beads for transcatheter arterial chemoembolization ¹æµµ¿¬(Àü³²´ëÇб³)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 16:05~16:20 Bile duct RFA È«ÇöÇ¥(¼º±Õ°üÀÇ´ë)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 16:20~16:50 ½Ã»ó ¹× Æóȸ ()

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:20~10:40 °øµ¿°³¾÷, ´Üµ¶°³¾÷ °æÇè Á¤ÇýµÎ, ¼º³«Á¾(¼­¿ï88ÀÇ¿ø, ¼­¿ïº½¿µ»óÀÇÇаú)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:40~10:55 ÇØ¿ÜÁøÃâ ÀÌÇõÁØ(UPMC, USA)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:55~11:10 ±¹³» ´ëÇк´¿ø±Ù¹«, ºÀÁ÷ÀÇ Çöµ¿È£, Á¶Á¤Çö(¼º±Õ°üÀÇ´ë, ´ëµ¿º´¿ø)

±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 11:10~11:20 Discussion ()

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:20~15:32 (±¸¿¬¹ßÇ¥) CTA and angiographic anatomy of prostatic artery in Korean population: A bicentric retrospective study À̽ÂÇö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:32~15:44 (±¸¿¬¹ßÇ¥) Comparison of the efficacy of pleural and intra-abdominal drainage between a double loop drainage catheter with absence of side holes in second loop and a conventional catheter ¹Ú»ó¿µ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:44~15:56 (±¸¿¬¹ßÇ¥) Packing a biloma with gelfoam slurry: an alternative treatment option for intractable bilomas unmanageable by conventional methods À̹«¼÷(°è¸íÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:56~16:08 (±¸¿¬¹ßÇ¥) Upper tract heparin instillation for maintenance of ureteral stent patency ±è¿ë»ó(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 16:08~16:20 (±¸¿¬¹ßÇ¥) Success Rate and Technical Aspect of Primary Transvenous Retrograde Terminal Duct Cannulation ÀüÅÂÁØ(¼º±Õ°üÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25
´ÙÀ½±Û Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 75 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 55 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 45 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 46 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷